Search
Cryo-Cell International Inc
CCELAdd to Watchlist
3.220USD
+0.030+0.94%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
25.94MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.94%
5 Days
-15.26%
1 Month
-9.30%
6 Months
-6.39%
Year to Date
-6.39%
1 Year
-36.49%
Key Figures
3.190Open
3.450High
16.53KVolume
LossP/E TTM
576.39P/E Dynamic
0.150Dividend TTM
0.21%Turnover Ratio
3.190Prev. Close
3.180Low
27.49KTurnover
64.51P/E Static
-1.41P/B
4.66%Div Yield TTM
-4.26%ROA
6.35052wk High
1.27Volume Ratio
402.10KNet Profit
8.06MShares
-0.3302EPS TTM
0.49Beta
129.20%ROE
2.72052wk Low
8.46%Amplitude
76.05%Gross Margin
25.94MMarket Cap
-1.39Reward/Risk
4.25%Risk Rate
TradingKey Stock Score of Cryo-Cell International Inc
Currency: USD Updated: 2026-06-30Key Insights
Cryo-Cell International Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 55 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 8.50.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cryo-Cell International Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Cryo-Cell International Inc Highlights
StrengthsRisks
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Growing
The company is in a growing phase, with the latest annual income totaling USD 31.57M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -9.66, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.00M shares, decreasing 7.58% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 209.44 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.56.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
8.500
Target Price
+86.81%
Upside Space
Cryo-Cell International Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cryo-Cell International Inc Info
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Ticker SymbolCCEL
CompanyCryo-Cell International Inc
CEOPortnoy (Mark L)
Websitehttps://www.cryo-cell.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%Popular Instruments
FAQs
What is the current price of Cryo-Cell International Inc (CCEL)?
The current price of Cryo-Cell International Inc (CCEL) is 3.22.
What is the symbol of Cryo-Cell International Inc?
The ticker symbol of Cryo-Cell International Inc is CCEL.
What is the 52-week high of Cryo-Cell International Inc?
The 52-week high of Cryo-Cell International Inc is 6.35.
What is the 52-week low of Cryo-Cell International Inc?
The 52-week low of Cryo-Cell International Inc is 2.72.
What is the market capitalization of Cryo-Cell International Inc?
The market capitalization of Cryo-Cell International Inc is 25.94M.
Is Cryo-Cell International Inc (CCEL) currently rated as Buy, Hold, or Sell?
According to analysts, Cryo-Cell International Inc (CCEL) has an overall rating of signal_hold, with a price target of 8.50.
What is the Earnings Per Share (EPS TTM) of Cryo-Cell International Inc (CCEL)?
The Earnings Per Share (EPS TTM) of Cryo-Cell International Inc (CCEL) is -0.30.